RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Radiation Injuries
Accession: DOID:9000111
browse the term
Definition: Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
Synonyms: exact_synonym: Radiation Injury; Radiation Sickness; Radiation Sicknesses; Radiation Syndrome; Radiation Syndromes; Radiation-induced nausea and vomiting
primary_id: MESH:D011832
xref: EFO:0006912 ; EFO:0009566
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:24333433
RGD:10059359
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
CSF2
colony stimulating factor 2
ISO
mRNA:increased expression:bone marrow,spleen:
RGD
PMID:7662961
RGD:10449513
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:20105084
RGD:401827914
NCBI chr 5:146,447,939...146,456,476
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:17340073
RGD:8695920
NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:7938676
RGD:7794763
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16540396 PMID:21945096
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
TGFBR2
transforming growth factor beta receptor 2
ISO
RGD
PMID:12957270
RGD:1601599
NCBI chr 3:30,536,187...30,623,653
Ensembl chr 3:30,854,460...30,938,856
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
DNA:missense mutation:cds:p.G671V (human)
RGD
PMID:16330681
RGD:11041175
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
G
ACVR2B
activin A receptor type 2B
treatment
ISO
human construct in mouse model
RGD
PMID:30765322
RGD:329849112
NCBI chr 3:38,350,838...38,389,839
Ensembl chr 3:38,633,093...38,662,063
G
CAPN2
calpain 2
treatment
ISO
RGD
PMID:25634181
RGD:13792617
NCBI chr 1:199,335,582...199,399,267
Ensembl chr 1:204,335,573...204,409,150
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human)
RGD
PMID:24284041
RGD:11252190
NCBI chr19:42,298,927...42,319,816
Ensembl chr19:50,897,004...50,915,819
G
ACACB
acetyl-CoA carboxylase beta
ISO
mRNA, protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr12:106,692,668...106,845,490
Ensembl chr12:110,086,374...110,239,847
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33676887
NCBI chr 1:206,252,141...206,263,830
Ensembl chr 1:211,279,015...211,291,044
G
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26145887
NCBI chr 3:162,794,184...162,858,574
Ensembl chr 3:170,845,494...170,911,481
G
BMP2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr20:6,765,161...6,777,728
Ensembl chr20:6,546,173...6,558,610
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35792220
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA, protein:decreased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr11:63,841,028...63,928,242
Ensembl chr11:67,144,736...67,205,481
G
CSF1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 1:112,555,755...112,575,894
Ensembl chr 1:127,764,916...127,781,943
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:hypermethylation:promoter
RGD
PMID:35462195
RGD:329951017
NCBI chr16:33,939,300...34,343,419
Ensembl chr16:53,023,425...53,490,231
G
HBEGF
heparin binding EGF like growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 5:135,699,553...135,713,366
Ensembl chr 5:141,816,402...141,830,531
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
KCNN2
potassium calcium-activated channel subfamily N member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32909839 PMID:33887967
NCBI chr 5:109,722,916...109,862,747
Ensembl chr 5:115,522,443...115,661,079
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34648132
NCBI chr 4:110,879,137...110,905,131
Ensembl chr 4:121,431,026...121,458,392
G
MLYCD
malonyl-CoA decarboxylase
ISO
protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr16:64,520,860...64,537,955
Ensembl chr16:83,912,793...83,929,162
G
NOS3
nitric oxide synthase 3
treatment
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human)
RGD
PMID:26345518
RGD:11533645
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
NPPB
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 1:10,621,416...10,622,960
Ensembl chr 1:11,838,518...11,839,995
G
NRG1
neuregulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 8:30,954,852...32,084,411
Ensembl chr 8:29,050,222...29,263,977
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
ISO
protein:decreased expression:serum, heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 1:55,928,577...55,998,628
Ensembl chr 1:57,664,237...57,702,227
G
RAC1
Rac family small GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28710503
NCBI chr 7:7,039,379...7,068,866
G
RARG
retinoic acid receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237429
NCBI chr12:35,521,276...35,542,814
Ensembl chr12:36,303,359...36,325,111
G
RNF10
ring finger protein 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36740146
NCBI chr12:118,117,486...118,160,341
Ensembl chr12:121,492,170...121,532,623
G
SIRT6
sirtuin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34713381
NCBI chr19:3,196,092...3,204,602
Ensembl chr19:4,146,057...4,154,126
G
TLR2
toll like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987 PMID:32068018
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30009776 PMID:34713381
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:14982483
RGD:6903857
NCBI chr 3:145,722,475...145,767,550
Ensembl chr 3:153,341,947...153,345,380
G
AGTR2
angiotensin II receptor type 2
ISO
RGD
PMID:14982483
RGD:6903857
NCBI chr X:105,252,903...105,257,171
Ensembl chr X:115,671,594...115,672,685
G
AIF1
allograft inflammatory factor 1
ISO
protein:decreased expression:brain (rat)
RGD
PMID:19070908
RGD:2313024
NCBI chr 6:31,276,215...31,278,051
Ensembl chr 6:32,166,301...32,168,125
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr 1:14,630,659...14,662,865
Ensembl chr 1:15,624,666...15,656,266
G
CCN2
cellular communication network factor 2
ISO
protein:increased expression:kidney (rat)
RGD
PMID:19080126
RGD:2314603
NCBI chr 6:129,729,572...129,733,113
Ensembl chr 6:133,836,319...133,842,077
G
ENG
endoglin
ISO
protein:decreased expression:lung (rat) kidney
RGD
PMID:22151990 PMID:23022174
RGD:7248771 RGD:7257525
NCBI chr 9:98,934,080...98,973,862
Ensembl chr 9:127,605,608...127,644,641
G
FAS
Fas cell surface death receptor
ISO
mRNA:increased expression:testis (rat)
RGD
PMID:9927315
RGD:8662886
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
protein:increased expression:white matter of spinal cord (rat) CTD Direct Evidence: therapeutic
RGD CTD
PMID:15161688 PMID:23065176
RGD:9068912
NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:22247972
RGD:10755582
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGF2
insulin like growth factor 2
ISO
mRNA:increased expression:brain
RGD
PMID:11213353
RGD:5509971
NCBI chr11:2,170,190...2,199,442
Ensembl chr11:2,202,743...2,228,890
G
IL10
interleukin 10
treatment
ISO
protein:increased expression:plasma
RGD
PMID:23788042 PMID:23968122
RGD:11049496 RGD:7365012
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
LCN2
lipocalin 2
ISO
mRNA,protein:increased expression:liver, heart, kidney,spleen, serum,
RGD
PMID:23331620
RGD:126790570
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr22:3,883,119...3,990,368
Ensembl chr22:20,365,487...20,450,335
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
Ensembl chr16:30,489,362...30,498,017
G
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20726721
NCBI chr12:114,784,232...114,938,385
Ensembl chr12:118,163,655...118,314,005
G
PCNA
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21931560
NCBI chr20:5,134,930...5,146,603
Ensembl chr20:4,927,731...4,939,440
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
mRNA:altered expression:jejunum, duodenum, ileum (rat)
RGD
PMID:22227376
RGD:6767294
NCBI chr17:58,417,134...58,526,409
Ensembl chr17:63,511,784...63,579,067
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr21:18,029,831...18,037,526
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11121210 PMID:20726721
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
ACE
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:8995730
RGD:12880012
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
SERPINE1
serpin family E member 1
treatment
ISO
RGD
PMID:8995730
RGD:12880012
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:1886988
RGD:4890434
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
G
ATM
ATM serine/threonine kinase
susceptibility
ISO
associated with lung cancer;DNA:SNPs:promoter:���111G>A,126713G>A (rs189037, s373759) (human)
RGD
PMID:20171797
RGD:150340755
NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041
G
C3
complement C3
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CBLB
Cbl proto-oncogene B
susceptibility
ISO
associated with lung non-small cell carcinoma; DNA:SNP,haplotype: :rs2305035(human)
RGD
PMID:26732495
RGD:150540334
NCBI chr 3:102,752,406...102,966,414
Ensembl chr 3:109,690,120...109,905,191
G
CCL17
C-C motif chemokine ligand 17
ISO
mRNA, protein:increased expression:lung, alveolar macrophage
RGD
PMID:15293604
RGD:4145517
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
G
CCL22
C-C motif chemokine ligand 22
ISO
mRNA, protein:increased expression:lung, alveolar macrophage
RGD
PMID:15293604
RGD:4145517
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
G
IL13
interleukin 13
susceptibility
ISO
associated with carcinoma, non-small-cell lung; DNA:SNPs: :rs20541, rs180925 (human)
RGD
PMID:20811626
RGD:5131286
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL1A
interleukin 1 alpha
susceptibility
ISO
associated with carcinoma, non-small-cell lung: DNA:SNPs: :rs1800587,rs17561(human)
RGD
PMID:20811626
RGD:5131286
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
LOC100984709
C4b-binding protein alpha chain
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr 1:182,707,221...182,747,878
Ensembl chr 1:186,985,264...187,025,898
G
MIF
macrophage migration inhibitory factor
susceptibility
ISO
associated with carcinoma, non-small-cell lung; DNA:SNP: :rs755622(human)
RGD
PMID:20811626
RGD:5131286
NCBI chr22:4,646,986...4,647,831
Ensembl chr22:22,730,807...22,732,009
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
associated with carcinoma, non-small-cell lung;DNA:SNP:cds:c.894G>T rs1799983 (human)
RGD
PMID:20811626
RGD:5131286
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
SFTPD
surfactant protein D
susceptibility
ISO
RGD
PMID:20459699
RGD:4143486
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
G
TGFB1
transforming growth factor beta 1
susceptibility
ISO
protein:increased expression:blood DNA:SNP:exon:869T>C (rs1982073) (human)
RGD
PMID:18411002 PMID:19380441 PMID:19943923
RGD:4145121 RGD:4145136 RGD:4145278
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TNF
tumor necrosis factor
susceptibility
ISO
associated with carcinoma, non-small-cell lung: DNA:SNPs: :rs1799724(human)
RGD
PMID:20811626
RGD:5131286
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:18347190
RGD:5131153
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
G
VTN
vitronectin
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr17:28,403,813...28,407,202
Ensembl chr17:28,906,508...28,909,583
G
CD274
CD274 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28736328
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21346772
NCBI chr19:30,223,567...30,226,204
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all